Manning & Napier Group, LLC / REGN
Manning & Napier Group, LLC’s Regeneron Pharmaceuticals Position
Does Manning & Napier Group, LLC own Regeneron Pharmaceuticals (REGN)? Not currently — the last reported position was 154.6K shares worth $63M in Q1 2019; the fund’s latest 13F (Q1 2024) no longer reports it.
Position Value
$63M
Q1 2019
Shares
154.6K
% of Portfolio
+0.69%
Quarters Held
1
position exited
Position History REGN
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2019 | 154.6K | $63M | +0.69% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Manning & Napier Group, LLC’s full portfolio or all institutional holders of REGN.